None listed
Conditions
Interventions
Dietary Supplement : Take RS or Placebo twice a day (morning and afternoon), 1 capsule at a time during meals or within 30 minutes after meals.
Sponsors
Bobsnu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult male and female over the age of 19 2) Those with a body mass index (BMI) of 25 kg/m2 or more and less than 35 kg/m2 at Visits 1 and 2 3) A person who has consented to participate in this human application test before the start of the human application test and filled out the Informed Consent Form
Exclusion criteria
Exclusion criteria: 1) Those currently receiving treatment for severe cardiovascular, immune, respiratory, hepatobiliary, renal and urinary systems, nervous system, musculoskeletal system, psychiatric, infectious disease, and malignant tumor 2) Drugs that affect body weight within 1 month (30 days) of visit 1 (obesity drugs (appetite suppressants, fat absorption inhibitors, GLP-1 receptor agonists, etc.), psychiatric drugs such as depression and schizophrenia, contraceptives, steroids Preparations, female hormones}, those who use health functional foods/supplements for weight control, herbal medicines, and formulas for weight control 3) Those who have received new beta-blockers or diuretics within 6 months of Visit 1, or those who are expected to change their dose during the trial period (However, if they are being administered without changing their dose from 6 months ago, they can participate) 4) Patients with uncontrolled hypertension (systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 100 mmHg, measurement standard after 10 minutes of rest for human subjects) 5) Diabetic patients whose glycated hemoglobin is 7.0% or higher or who are taking antidiabetic drugs (oral hypoglycemic agents, insulin, etc.) 6) Those with TSH of 0.1 µIU/mL or less or 10 µIU/mL or more 7) Those with GFR (Glomerular Filtration Rate) less than 45 mL/min 8) Those whose AST(GOT) or ALT(GPT) is 3 times or more of the normal upper limit of the implementing institution 9) Those who have problems with food intake for human application tests due to severe gastrointestinal disorders 10) People with alcohol use-induced disorders and central nervous system disorders 11) Those who are judged unable to exercise due to musculoskeletal disorders 12) Those who have had a weight change of 10% or more within 3 months based on visit 1 13) Those who participated in a commercial obesity program within 3 months of visit 1 14) Those who have participated in other interventional clinical trials (including human trials) within one month (30 days) of Visit 1, or who plan to participate in other interventional clinical trials (including human trials) after the start of this human trial 15) Those who are pregnant, lactating, or planning to become pregnant during this human application test period 16) Those who are sensitive to or allergic to the food ingredients for this human application test 17) Those who are judged inappropriate by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body fat mass, body fat percentage through DEXA | — |
Secondary
| Measure | Time frame |
|---|---|
| weight;Waist circumference, hip circumference, waist/hip ratio;Body Mass index; lean body mass through DEXA;Total Cholesterol, HDL-Cholesterol, LDL-Cholesterol, Triglyceride;hs-CRP;Adiponectin, Leptin | — |
Countries
Korea, Republic of
Contacts
Public ContactBelong Cho
Seoul National University Hospital
Outcome results
None listed